000280287 001__ 280287
000280287 005__ 20250831001841.0
000280287 0247_ $$2doi$$a10.1177/1877718X251343094
000280287 0247_ $$2pmid$$apmid:40462618
000280287 0247_ $$2ISSN$$a1877-7171
000280287 0247_ $$2ISSN$$a1877-718X
000280287 0247_ $$2altmetric$$aaltmetric:177865446
000280287 037__ $$aDZNE-2025-00942
000280287 041__ $$aEnglish
000280287 082__ $$a610
000280287 1001_ $$0P:(DE-2719)2811684$$aYe, Lan$$b0
000280287 245__ $$aTackling gender in progressive supranuclear palsy: Male patients present more apathy.
000280287 260__ $$aAmsterdam$$bIOS Press$$c2025
000280287 3367_ $$2DRIVER$$aarticle
000280287 3367_ $$2DataCite$$aOutput Types/Journal article
000280287 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1754901378_31915
000280287 3367_ $$2BibTeX$$aARTICLE
000280287 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000280287 3367_ $$00$$2EndNote$$aJournal Article
000280287 520__ $$aGender differences in progressive supranuclear palsy (PSP) may become relevant for clinical trials, treatment decisions and patient counseling. To study gender associated differences we conducted a retrospective data analysis of 191 male and 157 female PSP patients from a large multicenter observational cohort in Germany. While no differences in motor skills, disease severity, daily living abilities, global cognitive status and depressive symptoms were observed between genders, male patients showed significantly higher apathy scores, a finding also noted in other neurological diseases. In this study, apart from male patients exhibiting higher levels of apathy, no significant disease-specific gender differences were observed in PSP patients.
000280287 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000280287 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000280287 650_7 $$2Other$$aapathy
000280287 650_7 $$2Other$$agender
000280287 650_7 $$2Other$$aprogressive supranuclear palsy
000280287 650_2 $$2MeSH$$aHumans
000280287 650_2 $$2MeSH$$aSupranuclear Palsy, Progressive: physiopathology
000280287 650_2 $$2MeSH$$aSupranuclear Palsy, Progressive: psychology
000280287 650_2 $$2MeSH$$aSupranuclear Palsy, Progressive: complications
000280287 650_2 $$2MeSH$$aMale
000280287 650_2 $$2MeSH$$aApathy: physiology
000280287 650_2 $$2MeSH$$aFemale
000280287 650_2 $$2MeSH$$aAged
000280287 650_2 $$2MeSH$$aRetrospective Studies
000280287 650_2 $$2MeSH$$aMiddle Aged
000280287 650_2 $$2MeSH$$aSex Factors
000280287 650_2 $$2MeSH$$aSeverity of Illness Index
000280287 650_2 $$2MeSH$$aGermany
000280287 650_2 $$2MeSH$$aAged, 80 and over
000280287 650_2 $$2MeSH$$aDepression: etiology
000280287 7001_ $$aGreten, Stephan$$b1
000280287 7001_ $$0P:(DE-HGF)0$$aWilkens, Ida$$b2
000280287 7001_ $$aWegner, Florian$$b3
000280287 7001_ $$aKrey, Lea$$b4
000280287 7001_ $$0P:(DE-2719)2813308$$aHöllerhage, Matthias$$b5
000280287 7001_ $$00000-0001-7680-2147$$aPötter-Nerger, Monika$$b6
000280287 7001_ $$00009-0001-1175-177X$$aZeitzschel, Molly$$b7
000280287 7001_ $$00009-0003-3024-0689$$aHagena, Keno$$b8
000280287 7001_ $$0P:(DE-2719)9001967$$aKassubek, Jan$$b9
000280287 7001_ $$aSüß, Patrick$$b10
000280287 7001_ $$aWinkler, Jürgen$$b11
000280287 7001_ $$0P:(DE-2719)2000059$$aBerg, Daniela$$b12
000280287 7001_ $$00000-0002-9306-8332$$aPaschen, Steffen$$b13
000280287 7001_ $$aTönges, Lars$$b14
000280287 7001_ $$00009-0009-4335-4718$$aGruber, Doreen$$b15
000280287 7001_ $$00000-0003-2874-9817$$aGandor, Florin$$b16
000280287 7001_ $$aJost, Wolfgang H$$b17
000280287 7001_ $$0P:(DE-2719)2811089$$aKühn, Andrea A$$b18$$udzne
000280287 7001_ $$aClaus, Inga$$b19
000280287 7001_ $$aWarnecke, Tobias$$b20
000280287 7001_ $$00000-0002-5403-1959$$aPedrosa, David J$$b21
000280287 7001_ $$aEggers, Carsten$$b22
000280287 7001_ $$00000-0001-6407-1199$$aTrenkwalder, Claudia$$b23
000280287 7001_ $$00000-0001-7182-6967$$aClassen, Joseph$$b24
000280287 7001_ $$aSchwarz, Johannes$$b25
000280287 7001_ $$00000-0002-6414-7939$$aSchnitzler, Alfons$$b26
000280287 7001_ $$0P:(DE-2719)2811373$$aHöglinger, Günter$$b27$$udzne
000280287 7001_ $$00000-0002-3054-9905$$aKlietz, Martin$$b28
000280287 773__ $$0PERI:(DE-600)2599550-9$$a10.1177/1877718X251343094$$gVol. 15, no. 5, p. 1024 - 1028$$n5$$p1024 - 1028$$tJournal of Parkinson's Disease$$v15$$x1877-7171$$y2025
000280287 8564_ $$uhttps://pub.dzne.de/record/280287/files/DZNE-2025-00942.pdf$$yOpenAccess
000280287 8564_ $$uhttps://pub.dzne.de/record/280287/files/DZNE-2025-00942.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000280287 909CO $$ooai:pub.dzne.de:280287$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000280287 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001967$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b9$$kDZNE
000280287 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811089$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b18$$kDZNE
000280287 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2811373$$aExternal Institute$$b27$$kExtern
000280287 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000280287 9141_ $$y2025
000280287 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-27
000280287 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-27
000280287 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-27
000280287 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ PARKINSON DIS : 2022$$d2024-12-27
000280287 915__ $$0LIC:(DE-HGF)CCBYNC4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial CC BY-NC 4.0
000280287 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-10-23T11:51:45Z
000280287 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-10-23T11:51:45Z
000280287 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-27
000280287 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-27
000280287 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-27
000280287 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000280287 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-27
000280287 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-27
000280287 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ PARKINSON DIS : 2022$$d2024-12-27
000280287 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-27
000280287 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-27
000280287 9201_ $$0I:(DE-2719)5000077$$kClinical Study Center (Ulm)$$lClinical Study Center (Ulm)$$x0
000280287 9201_ $$0I:(DE-2719)5000008$$kAG Kühn$$lMovement Disorders (Parkinson's disease, Dystonia)$$x1
000280287 980__ $$ajournal
000280287 980__ $$aVDB
000280287 980__ $$aUNRESTRICTED
000280287 980__ $$aI:(DE-2719)5000077
000280287 980__ $$aI:(DE-2719)5000008
000280287 9801_ $$aFullTexts